Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,090 GBX | +0.28% |
|
-1.71% | +14.09% |
07-05 | AstraZeneca's Tagrisso Approved by EU as First-Line Treatment for Non-Small Cell Lung Cancer | MT |
07-05 | AstraZeneca: cancer treatment approved by the EU | CF |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.09% | 239B | |
+56.89% | 823B | |
+39.77% | 627B | |
-6.55% | 353B | |
+15.99% | 320B | |
+7.92% | 295B | |
+14.33% | 220B | |
-0.45% | 219B | |
+7.94% | 167B | |
-2.57% | 159B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca Pharma to Invest PLN 1.5 Billion in Polish R&D Operations